0 Ratings
ID

32535

Description

Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation

Keywords

Versions (1)
  1. 11/6/18 11/6/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

November 6, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059

    English

    Concomitant Medications

    1 forms  
    Concomitant Medications
    Description

    Concomitant Medications

    Alias
    UMLS CUI-1
    C2347852
    Sequence Number
    Description

    Concomitant Agent, Sequence Number

    Data type

    integer

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2348184
    Drug Name
    Description

    Concomitant Agent, Medication Name

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2360065
    Unit Dose
    Description

    Concomitant Agent, Dosage

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0178602
    Units
    Description

    Concomitant Agent, Unit of Measure

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C1519795
    Frequency
    Description

    Concomitant Agent, Frequencies

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0439603
    Route
    Description

    Concomitant Agent, Drug Administration Routes

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0013153
    Reason for Medication
    Description

    Concomitant Agent Use Indication

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826696
    Start Date and Time
    Description

    Concomitant Agent, Start Date, Start time

    Data type

    datetime

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0808070
    UMLS CUI [1,3]
    C1301880
    Taken Prior to Study ?
    Description

    Concomitant Agent, Before, Clinical Trial Period

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0332152
    UMLS CUI [1,3]
    C2347804
    Ongoing?
    Description

    Concomitant Medication ongoing

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2826666
    Concomitant Agent, End Date, End time
    Description

    Concomitant Agent, End Date, End time

    Data type

    datetime

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0806020
    UMLS CUI [1,3]
    C1522314
    Back to the top of the page

    Similar models

    Concomitant Medications

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Concomitant Medications
    C2347852 (UMLS CUI-1)
    Concomitant Agent, Sequence Number
    Item
    Sequence Number
    integer
    C2347852 (UMLS CUI [1,1])
    C2348184 (UMLS CUI [1,2])
    Concomitant Agent, Medication Name
    Item
    Drug Name
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Concomitant Agent, Dosage
    Item
    Unit Dose
    text
    C2347852 (UMLS CUI [1,1])
    C0178602 (UMLS CUI [1,2])
    Concomitant Agent, Unit of Measure
    Item
    Units
    text
    C2347852 (UMLS CUI [1,1])
    C1519795 (UMLS CUI [1,2])
    Concomitant Agent, Frequencies
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C0439603 (UMLS CUI [1,2])
    Concomitant Agent, Drug Administration Routes
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Agent Use Indication
    Item
    Reason for Medication
    text
    C2826696 (UMLS CUI [1])
    Concomitant Agent, Start Date, Start time
    Item
    Start Date and Time
    datetime
    C2347852 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    C1301880 (UMLS CUI [1,3])
    Concomitant Agent, Before, Clinical Trial Period
    Item
    Taken Prior to Study ?
    boolean
    C2347852 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Concomitant Medication ongoing
    Item
    Ongoing?
    boolean
    C2826666 (UMLS CUI [1])
    Concomitant Agent, End Date, End time
    Item
    datetime
    C2347852 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    C1522314 (UMLS CUI [1,3])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial